Exp Mol Med.
2006 Jun;38(3):210-216.
Delayed allograft rejection by the suppression of class II transactivator
- Affiliations
-
- 1Department of Pathology, Hallym University College of Medicine, Chuncheon 200-702, Korea. kwonik@hallym.ac.kr
- 2Division of Metabolic Diseases, Department of Biomedical Sciences, National Institute of Health, Seoul 122-701, Korea.
- 3Graduate Program of Immunology, Seoul National University College of Medicine, Seoul 110-799, Korea. jungkc66@snu.ac.kr
- 4Department of Pathology, Seoul National University College of Medicine, Seoul 110-799, Korea.
- 5Xenotransplantation Research Center, Seoul National University College of Medicine, Seoul 110-799, Korea.
Abstract
- We examined the effect of class II transactivator (CIITA) down-modulation on allograft rejection. To inhibit the function of CIITA, we constructed a series of CIITA mutants and found one exhibiting the dominant-negative effect on the regulation of major histocompatibility complex (MHC) class II expression. To test whether the CIITA dominant-negative mutant reduces immunogenecity, CIITA-transfected melanoma cells were injected into allogeneic host and assessed for immune evading activity against host immune cells. We demonstrated that the CIITA dominant-negative mutant allowed tumor nodules to develop earlier in the lung than control by this tumor challenge study. Furthermore, skin grafts deficient for CIITA also survived longer than wild-type in allogeneic hosts. Both the tumor challenge and skin graft studies suggest the inhibition of CIITA molecules in donor tissue would be beneficial to the control of allo-response.
Keyword
MeSH Terms
-
Transplantation, Homologous
Transfection
Trans-Activators/genetics/*immunology/metabolism
Trans-Activation (Genetics)/genetics/immunology
Skin Transplantation
Nuclear Proteins/genetics/*immunology/metabolism
Mutation
Mice, Transgenic
Mice, Knockout
Mice, Inbred C57BL
Mice, Inbred BALB C
Mice
Melanoma, Experimental/genetics/immunology/pathology
Male
Interferon Type II/pharmacology
Humans
Histocompatibility Antigens Class II/genetics/*immunology/metabolism
Graft Survival/genetics/immunology
Graft Rejection/genetics/*immunology
Genes, MHC Class II/genetics/immunology
Flow Cytometry
DNA, Complementary/genetics
Cell Proliferation/drug effects
Cell Line, Tumor
Animals
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Class II transactivator restricts viral replication, extending its effect to HBV: Editorial on “Novel role of MHC class II transactivator in hepatitis B virus replication and viral counteraction”
- Correspondence on editorial regarding “Novel role of MHC class II transactivator in hepatitis B virus replication and viral counteraction”
- Cytokine Production by Peripheral Blood Mononuclear Cells in Renal Transplantation Rejection and Their Effect on Expressions of ICAM-1 and HLA Class II Antigen
- Reply to correspondence on “Novel role of MHC class II transactivator in hepatitis B virus replication and viral counteraction”
- Impact of the Pattern of Acute Rejection Episodes on Graft Survival
